CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF ANTI-INFLAMMATORY DRUGS IN DISEASES SUCH AS NEURITIS AND NEURALGIA

Abstract

This article examines the clinical pharmacological principles guiding the use of anti-inflammatory drugs in the management of neuritis and neuralgia. These conditions, characterized by neuropathic pain and inflammatory damage to peripheral nerves, require a carefully balanced therapeutic approach that minimizes risks while ensuring effective symptom control. The discussion highlights the pharmacodynamic mechanisms of major anti-inflammatory classes, their safety considerations in neurological conditions, and the rationale for individualized therapy based on comorbidities, age, and drug–drug interactions. Special attention is given to steroidal and non-steroidal agents, adjuvant analgesics, and emerging neuroprotective strategies.